Core Insights - Three companies, Jianfa Zhixin, United Power, and Jinhua New Materials, were listed on September 25, with Jianfa Zhixin being a national high-value medical device distributor, United Power focusing on new energy vehicle power systems, and Jinhua New Materials specializing in fine chemicals [1][3][5]. Group 1: Jianfa Zhixin - Jianfa Zhixin operates as a high-value medical device distributor, providing direct sales and distribution services, and offering centralized operation services for medical consumables [1][2]. - The company is a subsidiary of Xiamen Jianfa Group, with the Xiamen State-owned Assets Supervision and Administration Commission indirectly holding 51.02% of its shares [1][2]. - For 2024, Jianfa Zhixin's revenue is projected to be divided into three segments: direct sales (11.032 billion, 61.69%), distribution (6.738 billion, 37.68%), and service (112 million, 0.63%) [1]. Group 2: United Power - United Power, established in 2016, is a provider of power systems for new energy vehicles, having been spun off from the industrial automation giant, Inovance Technology [3][4]. - The company is positioned as a leader in the new energy vehicle power system industry, participating in over 20 national standard formulations and providing solutions for over 40 vehicle manufacturers [4][5]. - In 2024, United Power is expected to deliver over 4.5 million power system products, collaborating with major domestic and international automotive brands [4]. Group 3: Jinhua New Materials - Jinhua New Materials specializes in the research, production, and sales of ketoxime series fine chemicals, being a leader in the domestic silane crosslinking agent market [5][6]. - The company's market share for silane crosslinking agents is projected to grow from 27.85% in 2022 to 38.16% in 2024 [6]. - Jinhua New Materials has received multiple honors, including being recognized as a national "little giant" enterprise and participating in the formulation of several national industry standards [6][7].

Group 1: Company Overview - Jianfa Zhixin (301584.SZ) is a national high-value medical device distributor, primarily engaged in direct sales and distribution of medical devices, providing centralized operation services for medical consumables to hospitals [1][4] - The company is a subsidiary of Xiamen Jianfa Group, with the State-owned Assets Supervision and Administration Commission of Xiamen City indirectly holding 51.02% of its shares [4] - In 2024, Jianfa Zhixin's revenue is expected to be divided into three main segments: direct sales (110.32 billion CNY, 61.69%), distribution (67.38 billion CNY, 37.68%), and service (1.12 billion CNY, 0.63%) [4] Group 2: Financial Performance - Jianfa Zhixin's initial public offering (IPO) price was 7.05 CNY per share, with a market capitalization of 29.70 billion CNY and an issuance price-to-earnings ratio of 13.29 [2] - The company has a high asset-liability ratio, with figures of 87.39%, 87.19%, and 86.45% from 2022 to 2024, indicating a capital-intensive business model [5] Group 3: Fundraising and Investment Plans - Jianfa Zhixin plans to allocate raised funds as follows: 1.40 billion CNY (28.94%) for information system upgrades, 1.04 billion CNY (21.49%) for centralized operation services, and 2.40 billion CNY (49.56%) for working capital [3] Group 4: Joint Power Company Overview - United Power (301656.SZ) was established in 2016 as a spin-off from the A-share giant Huichuan Technology, focusing on providing power systems for new energy vehicles [6][10] - The company is a leader in the new energy vehicle power system industry, participating in over 20 national standard formulations and providing solutions for more than 40 vehicle manufacturers [10] Group 5: Financial Performance of United Power - United Power's IPO price was 12.48 CNY per share, with a market capitalization of 300.1 billion CNY and an issuance price-to-earnings ratio of 32.87 [6] - The company reported accounts receivable values of 18.5 billion CNY, 36.1 billion CNY, and 56.8 billion CNY from 2022 to 2024, representing 20.37%, 29.38%, and 31.45% of total assets respectively [11] Group 6: Fundraising and Investment Plans of United Power - United Power intends to invest raised funds as follows: 26.12 billion CNY (53.77%) for core component production, 13.23 billion CNY (27.24%) for R&D center construction, and 8.00 billion CNY (16.47%) for working capital [8][9] Group 7: Jin Hua New Material Company Overview - Jin Hua New Material focuses on the research, production, and sales of ketoxime series fine chemicals, being a leader in the domestic silane crosslinking agent and hydroxylamine salt sectors [12][16] - The company has a market share of 27.85%, 31.60%, and 38.16% in silane crosslinking agents from 2022 to 2024 [16] Group 8: Financial Performance of Jin Hua New Material - The IPO price for Jin Hua New Material was 18.15 CNY per share, with an issuance price-to-earnings ratio of 11.52 [13] - The company has highlighted potential risks related to market demand fluctuations in downstream industries, particularly in real estate and photovoltaic sectors [17]